Discover
DRMA
Dermata Therapeutics, Inc.
1.38
2 x 1.01
2 x 1.65
bid
ask
+
0.09
6.98%
2 @ 04:00 PM
1.37 -0.01 (0.72%)
| Ytd | -40.52% | |
| 1y | -78.47% |
1.28
day range
1.41
1.10
52 week range
8.00
| Open | 1.29 | Prev Close | 1.29 | Low | 1.28 | High | 1.41 | Mkt Cap | 5.55M |
| Vol | 178.13K | Avg Vol | 74.82K | EPS | -4.17 | P/E | N/A | Forward P/E | -0.32 |
| Beta | 0.79 | Short Ratio | 0.52 | Inst. Own | 0.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.26 | 200-d Avg | 2.27 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 1.93M | ||
| Research and Development Expense | 383.72K | ||
| Selling, General and Administrative Expense | 1.54M | ||
| Operating Income | -1.93M | ||
| Net Income | -1.85M | ||
| Net Income Common Stock | -1.85M | ||
| Net Income Common Stock (USD) | -1.85M | ||
| Consolidated Income | -1.85M | ||
| Earnings per Basic Share | -0.48 | ||
| Earnings per Basic Share (USD) | -0.48 | ||
| Earnings per Diluted Share | -0.48 | ||
| Earning Before Interest & Taxes (EBIT) | -1.85M | ||
| Earning Before Interest & Taxes (USD) | -1.85M | ||
| Weighted Average Shares | 3.86M | ||
| Weighted Average Shares Diluted | 3.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.95M | ||
| Cash and Equivalents (USD) | 6.95M | ||
| Total Assets | 7.47M | ||
| Total Liabilities | 1.05M | ||
| Accumulated Retained Earnings (Deficit) | -75.08M | ||
| Shareholders Equity | 6.41M | ||
| Shareholders Equity (USD) | 6.41M | ||
| Inventory | 93.09K | ||
| Trade and Non-Trade Payables | 318.33K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -576.70K | ||
| Issuance (Purchase) of Equity Shares | 1.99M | ||
| Net Cash Flow from Operations | -2.48M | ||
| Share Based Compensation | 43.28K | ||